Standardized Chemical Allergen [EPC] — Patent Landscape

Aggregated US Orange Book patent estate across every drug in the standardized chemical allergen [epc] class. 66 active patents protecting 1 drugs. First major cliff: 2026. Daily refresh.

1
Drugs in class
66
Active US patents
67/100
Avg vulnerability
—
Annual revenue covered

Originators

Vero Biotech Inc 66 patents

Cliff calendar — next 15 years

2
26
1
27
28
29
2
30
26
31
3
35
3
36
1
40

Drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Inomax
NITRIC OXIDE
 Vero Biotech Inc 66 67 — 2026-10-17

Most attackable patents

Patent Drug Type Vuln Expiry
11931377 Inomax method of use 81 2029-06-30
11931377 Inomax method of use 81 2029-06-30
7947227 Inomax method of use 80 2026-10-17
8293284 Inomax method of use 73 2029-06-30
8846112 Inomax method of use 73 2029-06-30
8795741 Inomax method of use 73 2029-06-30
8431163 Inomax method of use 73 2029-06-30
8293284 Inomax method of use 73 2029-06-30
8431163 Inomax method of use 73 2029-06-30
8282966 Inomax method of use 73 2029-06-30

Strongest defences

Patent Drug Type Vuln Expiry
10213572 Inomax formulation 42 2036-02-12
10737051 Inomax formulation 42 2035-10-20
8607785 Inomax formulation 48 2030-07-14
11103669 Inomax formulation 48 2030-06-21
8944049 Inomax formulation 48 2029-08-13
10926054 Inomax formulation 48 2029-08-13
8573209 Inomax formulation 53 2031-01-06
8573209 Inomax formulation 53 2031-01-06
9701538 Inomax formulation 55 2029-01-28
11511252 Inomax formulation 56 2029-09-21

Related